FORIAN INC (FORA) Stock Fundamental Analysis
USA - NASDAQ:FORA - US34630N1063 - Common Stock
2.14 USD
-0.01 (-0.47%)
1.97 USD
-0.17 (-7.94%)
Taking everything into account, FORA scores 4 out of 10 in our fundamental rating. FORA was compared to 35 industry peers in the Health Care Technology industry. No worries on liquidiy or solvency for FORA as it has an excellent financial health rating, but there are worries on the profitability. FORA has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year FORA has reported negative net income.
In the past year FORA had a positive cash flow from operations.
FORA had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: FORA reported negative operating cash flow in multiple years.
1.2 Ratios
FORA has a better Return On Assets (-1.87%) than 77.14% of its industry peers.
FORA's Return On Equity of -2.93% is fine compared to the rest of the industry. FORA outperforms 77.14% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.87% | ||
| ROE | -2.93% | ||
| ROIC | N/A |
ROA(3y)-14.88%
ROA(5y)-26.21%
ROE(3y)-59.73%
ROE(5y)-65.77%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a Gross Margin value of 59.32%, FORA perfoms like the industry average, outperforming 51.43% of the companies in the same industry.
In the last couple of years the Gross Margin of FORA has grown nicely.
The Profit Margin and Operating Margin are not available for FORA so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 59.32% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.06%
GM growth 5Y6.47%
2. Health
2.1 Basic Checks
FORA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for FORA has been increased compared to 1 year ago.
Compared to 5 years ago, FORA has less shares outstanding
FORA has a better debt/assets ratio than last year.
2.2 Solvency
FORA has an Altman-Z score of 1.82. This is not the best score and indicates that FORA is in the grey zone with still only limited risk for bankruptcy at the moment.
FORA's Altman-Z score of 1.82 is fine compared to the rest of the industry. FORA outperforms 62.86% of its industry peers.
There is no outstanding debt for FORA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 2.6 | ||
| Altman-Z | 1.82 |
ROIC/WACCN/A
WACC10.36%
2.3 Liquidity
FORA has a Current Ratio of 2.66. This indicates that FORA is financially healthy and has no problem in meeting its short term obligations.
FORA's Current ratio of 2.66 is in line compared to the rest of the industry. FORA outperforms 54.29% of its industry peers.
A Quick Ratio of 2.66 indicates that FORA has no problem at all paying its short term obligations.
FORA has a Quick ratio (2.66) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.66 | ||
| Quick Ratio | 2.66 |
3. Growth
3.1 Past
FORA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -178.00%.
Looking at the last year, FORA shows a very strong growth in Revenue. The Revenue has grown by 22.86%.
Measured over the past years, FORA shows a small growth in Revenue. The Revenue has been growing by 5.68% on average per year.
EPS 1Y (TTM)-178%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%101.25%
Revenue 1Y (TTM)22.86%
Revenue growth 3Y6.09%
Revenue growth 5Y5.68%
Sales Q2Q%56.5%
3.2 Future
The Earnings Per Share is expected to grow by 66.28% on average over the next years. This is a very strong growth
FORA is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 27.73% yearly.
EPS Next Y151%
EPS Next 2Y66.28%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year48.18%
Revenue Next 2Y27.73%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
FORA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 23.31 indicates a rather expensive valuation of FORA.
71.43% of the companies in the same industry are more expensive than FORA, based on the Price/Forward Earnings ratio.
FORA's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 34.59.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 23.31 |
4.2 Price Multiples
FORA's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. FORA is cheaper than 77.14% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 25.43 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
FORA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
FORA's earnings are expected to grow with 66.28% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y66.28%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for FORA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
2.14
-0.01 (-0.47%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners13.31%
Inst Owner Change-3.47%
Ins Owners45.31%
Ins Owner Change11.37%
Market Cap66.58M
Revenue(TTM)25.03M
Net Income(TTM)-906.30K
Analysts82.86
Price Target5.1 (138.32%)
Short Float %1.84%
Short Ratio1.47
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-60.46%
Min EPS beat(2)-90.2%
Max EPS beat(2)-30.72%
EPS beat(4)2
Avg EPS beat(4)19.77%
Min EPS beat(4)-90.2%
Max EPS beat(4)132.68%
EPS beat(8)4
Avg EPS beat(8)55.8%
EPS beat(12)8
Avg EPS beat(12)46.01%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)15.62%
Min Revenue beat(2)2.29%
Max Revenue beat(2)28.95%
Revenue beat(4)3
Avg Revenue beat(4)8.21%
Min Revenue beat(4)-4.56%
Max Revenue beat(4)28.95%
Revenue beat(8)4
Avg Revenue beat(8)1.32%
Revenue beat(12)5
Avg Revenue beat(12)-3.27%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)20%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.08%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 23.31 | ||
| P/S | 2.66 | ||
| P/FCF | 25.43 | ||
| P/OCF | 25.43 | ||
| P/B | 2.15 | ||
| P/tB | 2.23 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.04
EYN/A
EPS(NY)0.09
Fwd EY4.29%
FCF(TTM)0.08
FCFY3.93%
OCF(TTM)0.08
OCFY3.93%
SpS0.8
BVpS0.99
TBVpS0.96
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.87% | ||
| ROE | -2.93% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 59.32% | ||
| FCFM | 10.46% |
ROA(3y)-14.88%
ROA(5y)-26.21%
ROE(3y)-59.73%
ROE(5y)-65.77%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.06%
GM growth 5Y6.47%
F-Score4
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 2.6 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.66 | ||
| Quick Ratio | 2.66 | ||
| Altman-Z | 1.82 |
F-Score4
WACC10.36%
ROIC/WACCN/A
Cap/Depr(3y)53.55%
Cap/Depr(5y)146.6%
Cap/Sales(3y)2.15%
Cap/Sales(5y)4.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-178%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%101.25%
EPS Next Y151%
EPS Next 2Y66.28%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)22.86%
Revenue growth 3Y6.09%
Revenue growth 5Y5.68%
Sales Q2Q%56.5%
Revenue Next Year48.18%
Revenue Next 2Y27.73%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y40.04%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-84.34%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y155.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y156.78%
OCF growth 3YN/A
OCF growth 5YN/A
FORIAN INC / FORA FAQ
What is the ChartMill fundamental rating of FORIAN INC (FORA) stock?
ChartMill assigns a fundamental rating of 4 / 10 to FORA.
What is the valuation status for FORA stock?
ChartMill assigns a valuation rating of 4 / 10 to FORIAN INC (FORA). This can be considered as Fairly Valued.
How profitable is FORIAN INC (FORA) stock?
FORIAN INC (FORA) has a profitability rating of 2 / 10.
Can you provide the expected EPS growth for FORA stock?
The Earnings per Share (EPS) of FORIAN INC (FORA) is expected to grow by 151% in the next year.